Announcement of the Winners of the 2022 CAAT Humane Education Award

Congratulations to Dr. Vivian Kral and Dr. Christian Zoschke from Free University Berlin, Germany, who won the 2022 CAAT Humane Education Award for their project titled “3Rs Info Hub PRO - Your go-to place for training on non-animal research”.

Each…

1 Min
More

Bayer to Accelerate Drug Discovery with Google Cloud’s High-Performance Compute Power

Bayer to speed up its in-silico research and development with Google Cloud’s high-speed processors / Collaboration aims to enable Bayer to run large quantum chemistry calculations at scale using Google Tensorflow Processing Units 

3 Min
More

ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology

ProBioGen announced today a new non-exclusive collaboration with Boehringer Ingelheim on ProBioGen's DirectedLuck® transposase technology.

2 Min
More

Review: "The Product is the Process – Is it?" Manufacturing and Translation of ATMPs and Tissue- & Cell-based products

An event held in cooperation with the Biotechnologieverbund Berlin-Brandenburg e.V., BBB; the Paul-Ehrlich-Institut; the Central Authority of the Länder for Health Protection with regard to Medicinal Products and Medical Devices, ZLG; the German Stem…

2 Min
More

DSM chooses LabTwin to advance their digitalization strategy in Science & Innovation with the latest voice and AI solutions.

DSM rolls out Labtwin's AI and voice powered digital lab assistant

Today, Royal DSM N.V., a global company specializing in health, nutrition, and sustainable living, and LabTwin GmbH, the leading voice and AI-powered digital lab assistant, announce…

3 Min
More

Therabest and Glycotope to assess Therabest’s iPSC-derived NK cell product TB-100 in combination with Glycotope’s GT-00AxIL15 immuno-cytokine for development in triple negative breast cancer

Therabest and Glycotope to assess Therabest’s iPSC-derived NK cell product TB-100 in combination with Glycotope’s GT-00AxIL15 immuno-cytokine for development in triple negative breast cancer

4 Min
More

OMEICOS Therapeutics Announces Expansion of OMT-28 Clinical Development Program into Primary Mitochondrial Diseases

OMT-28’s established safety profile, biomarker data, and funding secured from existing investors enable swift transition into a Phase II clinical study

2 Min
More

Interview | Prof. Dr. rer. nat. Heyo K. Kroemer, Chief Executive Officer of Charité – Universitätsmedizin Berlin

Diverse challenges and opportunities

3 Min
More

Special Topic | This is how the German capital region supports founders

The Berlin-Brandenburg capital region is one of the leading life science regions in Europe and a lot is being done to keep it that way: with a wide variety of space offerings and support program for founders and start-ups.

5 Min
More

Peter Fratzl elected to Chinese Chemical Society

Prestigious commendation

Max Planck Director Prof. Dr. Peter Fratzl has been appointed honorary life member by the Chinese Chemical Society (CCS). The CCS describes this nomination as "the highest honor bestowed on the world's most distinguished…

2 Min
More
Show more items